miRNA Expression Correlated with Morphological Findings in Chronic Myeloid Leukemia Treated with Imatinib Mesylate

Publisher： Karger

E-ISSN： 1421-9662|131|1|11-15

ISSN： 0001-5792

Source： Acta Haematologica, Vol.131, Iss.1, 2013-09, pp. : 11-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Apoptosis-Related Gene Expression Profile in Chronic Myeloid Leukemia Patients after Imatinib Mesylate and Dasatinib Therapy

By  

Acta Haematologica, Vol. 133, Iss. 4, 2015-02 ,pp. : 354-364

Karger

Access to resources Recommend Favorite

Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 4, 2012-04 ,pp. : 228-234

Karger

Access to resources Recommend Favorite

Squamous cell carcinoma in a chronic myelogenous leukemia patient treated with imatinib mesylate

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 3, 2015-03 ,pp. : 338-339

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

By  

Acta Haematologica, Vol. 120, Iss. 3, 2008-11 ,pp. : 146-149

Karger

Access to resources Recommend Favorite

Gelatinous Transformation of Bone Marrow in Chronic Myeloid Leukemia during Treatment with Imatinib Mesylate: A Disease or a Drug Effect?

By  

Acta Haematologica, Vol. 119, Iss. 2, 2008-03 ,pp. : 104-107

Karger

Access to resources Recommend Favorite